LSBio provides high-quality antibodies, proteins, ELISA and assay kits to researchers worldwide. Founded in 1995, LSBio was established as a molecular pathology company with a focus on protein localization in diseased human tissues by IHC. Through the experience gained by executing thousands of IHC studies, and generating and testing many thousands of antibodies, LSBio has become a world leader in the antibody industry, with a reputation for excellence.
LSBio’s catalog includes 550,000 monoclonal and polyclonal antibodies to 20,000 targets. Antibodies are available for most species and all major research applications, such as IHC, IF, WB and FACS. Through extensive ongoing in-house testing, more than 15,000 of these antibodies have also been identified as exceptional IHC reagents and given the IHC-plus™ brand. LSBio also offers 30,000 high quality immunoassays, including sandwich ELISA (enzyme-linked immunosorbent assay) kits and competitive EIA (enzyme immunoassay) kits, as well as cell-based and DNA-binding kits.
In 2022, LSBio became part of Absolute Biotech, a new company that unites multiple life science brands into one organization specializing in antibody reagents and services. Learn more at absolutebiotech.com.